GlobalData on MSN3 天
Allay doses first subject in trial of ATX101 for post-surgical pain relief
Allay Therapeutics has dosed the first subject in the randomised Phase IIb registration trial of its investigational ...
North Queensland Register4 天
How Australia is helping Indonesia tackle foot and mouth disease outbreak
Versatile Australian-developed livestock pain relief treatment Tri-Solfen is proving its worth as a treatment for foot and ...
Business Wire4 天
Allay Therapeutics Announces First Patients Dosed in Pivotal Phase 2b Registration Trial of ...
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management an ...
MyChesCo on MSN6 天
Virpax Pharmaceuticals Advances Pain Management with Promising Probudur Study Results
BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced the successful completion of a full study on its ...